C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants-Reference-Cited by-同舟云学术

C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants

Published:2016-04-15 Issue:6 Volume:56 Page:1442-1450
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Jackman Rachael P.¹,Lee Jar-How²,Pei Rui²,Bolgiano Douglas³,Lebedeva Mila¹,Slichter Sherrill J.³⁴,Norris Philip J.¹⁵

Affiliation:

1. Blood Systems Research Institute; San Francisco California

2. Thermo Fisher Scientific; Canoga Park California

3. Bloodworks Northwest (formerly Puget Sound Blood Center)

4. University of Washington School of Medicine; Seattle Washington

5. University of California; San Francisco California

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13598/fullpdf

Reference36 articles.

1. The natural history of alloimmunization to platelets;Howard;Transfusion,1978

2. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients;Slichter;Blood,2005

3. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation;Itescu;Circulation,1998

4. Factors influencing HLA sensitization in implantable LVAD recipients;Massad;Ann Thorac Surg,1997

5. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support;Moazami;J Heart Lung Transplant,1998

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects;Frontiers in Immunology;2023-02-09

2. Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages;Platelets;2022-10-03

3. Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets;Haematologica;2022-03-31

4. The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy;Frontiers in Immunology;2022-02-09

5. Transfusion‐induced platelet antibodies and regulatory T cells in multiply transfused patients;Journal of Clinical Laboratory Analysis;2021-06-14